FIRM FIXED PRICE

TAKEDA PHARMACEUTICALS AMERICA INC - FY26 PHARMACY TAKEDA JAN-SEPT

PIID: 15B50926F00000053
Signed Date: Feb 11, 2026Effective Date: Feb 28, 2026End Date: Closed on Feb 28, 2026
Award $
$205K
Vendor
TAKEDA PHARMACEUTICALS AMERICA INC
NAICS
325412
Signed Date
Feb 11, 2026

Key Details

Dollars Obligated
$204,577.58
Base & All Options
$204,577.58
Awarding Agency
Department of Justice
Awarding Sub-Agency
Federal Prison System / Bureau of Prisons
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
LEXINGTON, MA, 024217942, CD-MA-05

Description

FY26 PHARMACY TAKEDA JAN-SEPT

Context & Analysis

On Feb 11, 2026, Department of Justice obligated $204,577.58 to TAKEDA PHARMACEUTICALS AMERICA INC for fy26 pharmacy takeda jan-sept. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in LEXINGTON, MA.

Contractor Information

UEI: DDEVYUAXJ624
CAGE Code: 4DE70
Location: DEERFIELD, IL
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related